ResearcherJiangnan UniversityActive in the last 2 years

Jin‐Song Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8514-3112; OpenAlex author ID A5051831791. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer. Co-author DOI 10.1016/j.gene.2023.148007 ↗
GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer. Last author DOI 10.7717/peerj.12728 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chen Chen · 2 shared papers, 2022–2024 · strength 0.41
- Paper Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer. DOI 10.1016/j.gene.2023.148007 ↗
- Paper GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer. DOI 10.7717/peerj.12728 ↗
Dangran Li · 1 shared paper, 2024 · strength 0.23
- Paper Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer. DOI 10.1016/j.gene.2023.148007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.